Search clinical trials for: Machine learning algorithm

Total 10000 results

‹
1
2
...
49
50
51
52
53
54
55
...
199
200
›

GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults

Infections, Staphylococcal

Belgium
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies Vaccine

Rabies | Rabies Virus

China
Novartis

Completed

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants

Typhoid Fever

Philippines
University of Bologna

Completed

Dynamic Navigation for Zygomatic Implant Rehabilitation Using an Intraoral Reference System: Evaluation of a New Zygomatic Implant Design (NAVIZYG-SURF)

Atrophic Maxilla | Zygomatic Implants | Implant Surface
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Healthy Volunteers (Meningococcal Infection)

United States, Puerto Rico
GlaxoSmithKline

Completed

Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

Hepatitis B | Tetanus | Diphtheria | Haemophilus Influenzae Type b | Whole Cell Pertussis

Philippines
National Institute of Allergy and Infectious Diseases...
The Emmes Company, LLC

Completed

Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone

Influenza

United States
University of Pittsburgh
National Institute on Aging (NIA)

Completed

Thinking, Walking Outcomes by Type of Exercise (2-STEP)

Gait Disorder, Sensorimotor | Cognitive Disorder

United States
Tan Tock Seng Hospital
Sanofi; University of Melbourne; A*Star

Completed

Immunogenicity Trial of 3 Influenza Vaccines

Influenza Vaccination

Singapore
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

Meningitis, Meningococcal

United States, Australia, Argentina, Canada
International Centre for Diarrhoeal Disease Research...

Not yet recruiting

Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)

Polio
University of Alabama at Birmingham

Active, not recruiting

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

Influenza

United States
ModernaTX, Inc.

Completed

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults

Influenza

United States
Nuravax, Inc.
Arvax

Completed

Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine

Alzheimer Disease | Alzheimer Disease (AD) | Alzheimers Disease Prevention

Australia
Seqirus

Completed

A Study to Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® Vaccine in Healthy Volunteers

Influenza, Human

United Kingdom
University of Calgary

Completed

Adjusting Fluid Removal Based on Blood Volume in Hemodialysis: A Randomized Study

End Stage Renal Failure on Dialysis | Intradialytic Hypotension

Canada
GlaxoSmithKline

Completed

Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.

Sexually Transmitted Diseases

United States, Philippines, Spain, Germany, United Kingdom, South Africa, France, Brazil
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults

HIV Infections

United States, South Africa
GlaxoSmithKline

Recruiting

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

Urinary Tract Infections

South Africa, United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

Meningococcal Infections

Czechia, Finland, Italy, Poland, Romania, Spain, Sweden
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers

Venous Thrombosis
National Cancer Institute (NCI)

Active, not recruiting

Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants

Human Papillomavirus-Related Carcinoma

United States
GlaxoSmithKline

Completed

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines

Infections, Streptococcal

Poland, Philippines
Jiangsu Province Centers for Disease Control and...

Completed

The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates

Hepadnaviridae Infections | DNA Virus Infections | Virus Disease

China
Bandim Health Project
Université Libre de Bruxelles; The University of Western Australia

Recruiting

Measles and BCG Vaccines for Mother and Child (MATVAC)

Measles | Vaccine Preventable Disease | BCG Vaccination Reaction | Mother-Infant Interaction

Guinea-Bissau
GlaxoSmithKline

Completed

Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years

Meningitis, Meningococcal

Czechia
The Immunobiological Technology Institute (Bio-Manguinhos)...
Bill and Melinda Gates Foundation

Completed

Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella (MR)

Measles | Rubella

Brazil
Centers for Disease Control and Prevention, China

Unknown

Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month

Influenza | Swine-origin A/H1N1 Influenza

China
Vaxcyte, Inc.

Active, not recruiting

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age

Pneumococcal Vaccines

United States
Immune Design

Terminated

A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)

Sarcoma | Soft Tissue Sarcoma | Cancer | Synovial Sarcoma | Metastatic Sarcoma

United States, Canada
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent

Healthy

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers

Healthy Volunteers

United States
UMC Utrecht
Netherlands Organisation for Scientific Research

Completed

Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid)

Recurrent Upper and Lower Respiratory Tract Infections (RTIs)

Netherlands
GlaxoSmithKline

Completed

A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults

Infections, Meningococcal

United States, Australia, Finland, Poland, Belgium, Sweden, Brazil, Turkey
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Study of BCG Vaccine for Intradermal Injection

Tuberculosis

China
Sanofi Pasteur, a Sanofi Company

Completed

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

Influenza

United States
GlaxoSmithKline

Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

Respiratory Syncytial Virus Infections

United States, Belgium
African Malaria Network Trust
London School of Hygiene and Tropical Medicine

Unknown

Phase Ib Trial of MSP3 LSP in Children in Tanzania (MSP3TN)

Malaria

Tanzania
Auro Vaccines LLC
United States Department of Defense; Accelovance

Completed

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

Ebola Virus Disease

United States
Baylor Research Institute

Terminated

Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients

Malignant Melanoma Stage IV

United States
National Liver Institute, Egypt

Unknown

Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection (CENV3)

Vaccine Overdose of Undetermined Intent

Egypt
Sanofi

Completed

Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV

Pertussis | Tetanus | Diphtheria | Poliomyelitis

Korea, Republic of
Novartis
Novartis Vaccines

Completed

Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine

Influenza Infection

Switzerland
University of Lahore

Completed

MRP Verses PNF on Pain, Foot Drop, Gait and Functional Mobility in Hemiplegic Patients. (CEMRA-PNF)

Stroke | Pain | Hemiplegia | Foot Drop | Gait, Drop Foot

Pakistan
Children's Hospital of Fudan University

Completed

Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty

Precocious Puberty

China
Kaohsiung Medical University Chung-Ho Memorial...

Completed

Improvements in Pneumonia Status After Oral Care Intervention in Taiwan

Pneumonia
Hadassah Medical Organization

Unknown

Safety and Efficacy of Low Intensity Shockwave Therapy in Treating Diabetic Foot Ulcers

Diabetic Foot Ulcers
American University of Beirut Medical Center

Completed

PEG-Electrolyte Solution (FORTRANS®) With Mentholyptus Drops (Halls®) Versus Reduced Volume Ascorbic Acid Supplemented PEG-Electrolyte (MoviPrep®) in Colonoscopy Preparation

Bowel Cleansing in Preparation for Colonoscopy

Lebanon
Arcturus Therapeutics, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults

Influenza, Human

United States
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...
UnitedHealthcare

Active, not recruiting

Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix (COVSP-BCG)

Covid19

United States

‹
1
2
...
49
50
51
52
53
54
55
...
199
200
›

Subscribe